Citations

Lessells, R. J, G. S Cooke, N. McGrath, M. P Nicol, M. L Newell, and P. Godfrey-Faussett. "Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial." Am J Respir Crit Care Med 196, no. 7 (2017): 901-910.

Rochat, T. J, B. Houle, A. Stein, R. M Pearson, M. L Newell, and R. M Bland. "Cohort Profile: The Siyakhula Cohort, rural South Africa." Int J Epidemiol 47, no. 2 (2018).

Iwuji, C., N. McGrath, A. Calmy, F. Dabis, D. Pillay, M. L Newell, K. Baisley, and K. Porter. "Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial." J Int AIDS Soc 21, no. 6 (2018).

Rochat, T. J, B. Houle, A. Stein, R. M Pearson, M. L Newell, and R. M Bland. "Psychological morbidity and parenting stress in mothers of primary school children by timing of acquisition of HIV infection: a longitudinal cohort study in rural South Africa." J Dev Orig Health Dis 9, no. 1 (2018): 41-57.

Simoni, Y., M. Fehlings, h. M Kloverpris, N. McGovern, S. L Koo, C. L Loh, S. L Lim, A. Kurioka, J. R Fergusson, C. L Tang, M. H Kam, K. Dennis, T. K H Lim, A. C Y Fui, C. W Hoong, J. K Y Chan, M. Curotto de Lafaille, S. Narayanan, S. Baig, M. Shabeer, S. E S Toh, H. K K Tan, R. Anicete, E. H Tan, A. Takano, P. Klenerman, A. Leslie, D. S W Tan, I. B Tan, F. Ginhoux, and E. W Newell. "Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency." Immunity 46, no. 1 (2017): 148-161.

Houle, B., T. J Rochat, M. L Newell, A. Stein, and R. M Bland. "Breastfeeding, HIV exposure, childhood obesity, and prehypertension: A South African cohort study." PLoS Med 16, no. 8 (2019).

Iwuji, C. C, J. Iwuji, J. Larmarange, E. Balestre, R. Thiebaut, F. Tanser, N. Okesola, T. Makowa, J. Dreyer, K. Herbst, N. McGrath, T. Barnighausen, S. Boyer, T. De Oliveira, C. Rekacewicz, B. Bazin, M. L Newell, D. Pillay, F. Dabis, and Anrs TasP Study Group. "Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial." Lancet HIV 5, no. 3 (2018): e116-e125.